Acerta 36
Prolonged-release tablet
registration number
51/1.2/0287
What Acerta 36 contains
Methylphenindate HCl 36 mg.
other ingredients
Tablet content: fumaric acid, hypromellose, lactose monohydrate, magnesium stearate, methacrylic acid–methyl methacrylate copolymer, colloidal anhydrous silica, triethyl citrate and talc
Tablet coating: macrogol (3350), part hydrolysed polyvinyl alcohol, talc and titanium dioxide (E171)
Printing ink: iron oxide black (E172), isopropyl alcohol and shellac glaze.
Therapeutic classification
N06B A04 - centrally acting sympathomimetics.